AtriCure Financials
| ATRC Stock | USD 31.30 0.58 1.89% |
Understanding current and past AtriCure Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AtriCure's financial statements are interrelated, with each one affecting the others. For example, an increase in AtriCure's assets may result in an increase in income on the income statement.
Please note, the presentation of AtriCure's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AtriCure's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AtriCure's management manipulating its earnings.
AtriCure Stock Summary
AtriCure competes with AngioDynamics, Axogen, CONMED, and LeMaitre Vascular. AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company was incorporated in 2000 and is headquartered in Mason, Ohio. Atricure operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 875 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US04963C2098 |
| CUSIP | 04963C209 |
| Location | Ohio; U.S.A |
| Business Address | 7555 Innovation Way, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.atricure.com |
| Phone | 513 755 4100 |
| Currency | USD - US Dollar |
AtriCure Key Financial Ratios
| Return On Equity | -0.0838 | ||||
| Return On Asset | -0.037 | ||||
| Target Price | 49.89 | ||||
| Beta | 1.6 |
AtriCure Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AtriCure's current stock value. Our valuation model uses many indicators to compare AtriCure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AtriCure competition to find correlations between indicators driving AtriCure's intrinsic value. More Info.AtriCure is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AtriCure's earnings, one of the primary drivers of an investment's value.AtriCure Systematic Risk
AtriCure's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AtriCure volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on AtriCure correlated with the market. If Beta is less than 0 AtriCure generally moves in the opposite direction as compared to the market. If AtriCure Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AtriCure is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AtriCure is generally in the same direction as the market. If Beta > 1 AtriCure moves generally in the same direction as, but more than the movement of the benchmark.
About AtriCure Financials
What exactly are AtriCure Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include AtriCure's income statement, its balance sheet, and the statement of cash flows. Potential AtriCure investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although AtriCure investors may use each financial statement separately, they are all related. The changes in AtriCure's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AtriCure's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.AtriCure July 15, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AtriCure help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AtriCure. We use our internally-developed statistical techniques to arrive at the intrinsic value of AtriCure based on widely used predictive technical indicators. In general, we focus on analyzing AtriCure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AtriCure's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 17.56 | |||
| Value At Risk | (3.04) | |||
| Potential Upside | 2.91 |
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |